Eli Lilly Stock Tumbles on Weak Q3 Results, Sales Falling Short

November 06, 2024

Eli Lilly and Company, a leading pharmaceutical company, faced a challenging third quarter as its sales and profits fell well short of estimates. The company reported a miss on both its revenue and earnings, leading to a significant drop in its stock price. The disappointing performance was mainly attributed to a decline in sales of Zepbound, one of Eli Lilly's key products. The company had hoped for stronger sales, but it seems that the market demand was not as high as anticipated. Investors are now wondering what steps Eli Lilly will take to turn its fortunes around and whether it is a good time to buy, sell, or hold the company's stock. For professional insight and guidance on the forecasted movement of Eli Lilly's stock, it is recommended to consult with experts from Stocks Prognosis.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY

Investor opinions & comments:

I'm skeptical about the company's ability to turn their fortunes around. They may need to make some significant changes

— from BrianMartin at 11-09-2024 08:11

I'm disappointed in Eli Lilly's performance. It's disheartening to see such a decline in sales and profits

— from CashClaire at 11-09-2024 00:00

I have faith in Eli Lilly's ability to adapt and recover. Their history of innovation has been impressive

— from SavingsSandy at 11-08-2024 23:00

I'm considering selling my shares of Eli Lilly. The weak Q3 results are a red flag for me

— from FinanceFelix at 11-08-2024 18:27

The pharmaceutical industry is cyclical, and I believe Eli Lilly will bounce back. They have a talented team

— from WealthyWhitney at 11-08-2024 13:34

Eli Lilly has a strong track record of success. I'm confident that they will rebound from this setback

— from TraderTina at 11-08-2024 13:30

I believe in the long-term potential of Eli Lilly. This may be a good opportunity to buy their stock at a lower price

— from FinanceFlo at 11-08-2024 10:24

I'm not convinced that the decline in sales is solely due to market demand. There could be other factors at play

— from VictoriaKelley at 11-08-2024 09:18

I'm optimistic about Eli Lilly's future. They have a solid pipeline of potential new drugs

— from RileyHughes at 11-07-2024 23:44

I'm losing faith in Eli Lilly. Their inability to meet revenue and earnings expectations is concerning

— from CashClaire at 11-07-2024 18:16

The decline in sales is concerning. I'm not sure if this is just a temporary setback or a sign of deeper issues

— from AnthonyBennett at 11-07-2024 15:30

I hope Eli Lilly can bounce back soon. They have been a key player in the pharmaceutical industry

— from MeganThompson at 11-07-2024 06:47

I wonder if Eli Lilly's competitors are also experiencing a decline in sales. It would be interesting to compare their performance

— from MoneyMandy at 11-07-2024 01:16

I'm curious to see how Eli Lilly plans to turn their sales around. Hopefully, they can come up with a new strategy

— from GrowthGina at 11-06-2024 22:09

Eli Lilly has been a reliable company in the past. I trust that they will find a way to overcome this setback

— from StockSally at 11-06-2024 20:08

If you want to leave a comment, then you need Login or Register

Other news for LLY

March 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

March 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

March 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

March 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

March 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry? ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

Related news

November 14, 2024Eli Lilly and Company LLY: Breaking Barriers in Pharma Industry ~2 min.

Eli Lilly and Company, a leading pharmaceutical giant, has recently achieved a major milestone that has left investors disappointed....

March 20, 2025Investor Disappointment Causes Novo Nordisk AS NVO Stocks to Trade Lower ~2 min.

Novo Nordisk AS, a leading pharmaceutical company, has experienced a decline in stock prices due to investor disappointment over its new drug in obesity....

January 22, 2025Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing a securities class action after suffering a massive value loss of 9 billion following their Q3 2024 earnings report....

November 2, 2024Eli Lilly stock tumbles on Q3 miss ~1 min.

Eli Lilly and Company, a global pharmaceutical giant, experienced a significant drop in its stock value following the release of its Q3 earnings report....

November 14, 2024AbbVie Faces Setback as Schizophrenia Drug Trials Fall Short ~2 min.

Pharmaceutical giant AbbVie Inc. (ABBV) experienced a significant drop in stock prices today, following disappointing results from their latest schizophrenia drug trials....

Search on StockPrognosis.com

Sections of the site

Eli Lilly Stock Tumbles on Weak Q3 Results, Sales Falling Short

Find out how the ELI LILLY AND COMPANY rate is expected to change

Investor opinions & comments:

Other news for LLY

Related news

Stocks-Prognosis.com © 2025